On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…
On Jul. 6, 2020, Merck announced a new analyses from the Phase 2b trial evaluating the safety and…
On Jul. 6, 2020, the European Investment Bank (EIB) and CureVac announced they had entered into a $75…
On Jul. 6, 2020, the FDA issued an emergency use authorization (EUA) for the third diagnostic test for…
On Jul. 6, 2020, Endo International announced that it received FDA approval of Qwo (collagenase clostridium histolyticum-aaes) for…
On Jul. 6, 2020, the lack of universal recognition that COVID-19 is transmitted via airborne particles, along with…
On Jul. 6, 2020, Sinovac Biotech announced that on Jul. 3, 2020, the Brazilian National Regulatory Agency, Anvisa,…
On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…
On Jul. 6, 2020, Emergent BioSolutions announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, a Johnson &…
On Jul. 6, 2020, Anixa Biosciences announced that it and partner OntoChem had completed the initial in silico…
On Jul. 6, 2020, Anixa Biosciences announced that it and partner OntoChem had identified additional candidates through their…
On Jul. 6, 2020, AIM ImmunoTech announced that it had signed a material transfer and research agreement with…
On Jul. 6, 2020, ADMA Biologics announced the commencement of operations and initiation of collections at its newest…
On Jul. 6, 2020, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) had granted Emergency…
On Jul. 6, 2020, Regeneron announced initiation of late-stage clinical trials evaluating REGN-COV2, Regeneron’s investigational double antibody cocktail…
On Jul. 6, 2020, Meridian HSN announced it had partnered with Moto-Para and Todos Medical to provide a…
On Jul. 6, 2020, Mylan announced that the Drug Controller General of India (DCGI) has approved its remdesivir…
On Jul. 4, 2020, WHO accepted the recommendation from the Solidarity Trialï¾’s International Steering Committee to discontinue the…
On Jul. 3, 2020, Gilead Sciences announced the European Commission had granted conditional marketing authorization for Vekluryï¾® (remdesivir)…
On Jul. 3, 2020, CytoDyn announced it had signed an exclusive Distribution and Supply Agreement with American Regent…
On Jul. 2, 2020, Abivax announced that the first patient has been treated in its Phase 2b/3 study…
On Jul. 2, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
On Jul. 2, 2020, the U.S. Food and Drug Administration (FDA) approved Rukobia (fostemsavir), a new type of…
On Jul. 2, 2020, the Centers for Disease Control and Prevention announced a publication in the journal Proceedings…
On Jul. 2, 2020, Royal Philips announced that the FDA had issued an Emergency Use Authorization (EUA) for…
On Jul. 2, 2020, in response to the continuing need for more COVID-19 diagnostic tests, the Translational Genomics…
On Jul. 2, 2020, scientists from Duke University, Los Alamos National Laboratory and La Jolla Institute for Immunology…
On Jul. 2, 2020, UConn announced a licensing deal with Connecticut Biotech, a startup company headquartered in South…
On Jul. 2, 2020, Maxim Biomedical announced plans to produce and market as many as 3 million Maxim…
On Jul. 2, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…